Nucleus RadioPharma Appoints Chris McDonald as Global Head of Technical Operations
Company
Nucleus RadioPharma
Description
Nucleus RadioPharma announced the appointment of Chris McDonald, Global Head of Technical Operations at Kite, a Gilead Company, to its Board of Directors. This addition underscores Nucleus RadioPharma's focus on operational excellence and its commitment to research and development, specifically tailored to the unique demands of the radiopharmaceutical sector.
Quick answer
Nucleus RadioPharma Appoints Chris McDonald as Global Head of Technical Operations (March 27, 2024). Nucleus RadioPharma is based in Davidson, North Carolina, United States.
- What did Nucleus RadioPharma announce on March 27, 2024?
- Nucleus RadioPharma announced the appointment of Chris McDonald, Global Head of Technical Operations at Kite, a Gilead Company, to its Board of Directors. This addition underscores Nucleus RadioPharma's focus on operational excellence and its commitment to research and development, specifically tailored to the unique demands of the radiopharmaceutical sector.
- What does Nucleus RadioPharma do?
- Nucleus RadioPharma is an innovative CDMO dedicated to the development and manufacturing of targeted radiotherapies.
- Where is Nucleus RadioPharma based?
- Nucleus RadioPharma is based in Davidson, North Carolina, United States.
- Which similar companies made leadership changes around the same time?
- Experic (April 3, 2024), VGXI (March 27, 2024), DDL (March 27, 2024) and BioFuse Medical Technologies (March 26, 2024) also announced leadership changes within 45 days of Nucleus RadioPharma.
Source: Fundz verified event record.
Other recent leadership changes in pharmaceuticals and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Experic Appoints Philip Dunne as Director of EU Operations in Dublin, Ireland (April 3, 2024)
- VGXI Appoints Stephanie Burke as Chief Accounting Officer (March 27, 2024)
- DDL Names Abhi Gautam as Executive Engineer to Lead New Consulting Services Offering (March 27, 2024)
- BioFuse Medical Technologies Appoints Dr. David Battleman as President & Chief Executive Officer (March 26, 2024)
- RIVANNA Names Craig Loomis as Senior Director of Product Management (March 29, 2024)
- Applied BioCode Retires Chris Bernard as CEO, Appoints Dr. Winston Ho as New CEO (March 21, 2024)
Who to call at Nucleus RadioPharma, and when
A new leader at Nucleus RadioPharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nucleus RadioPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nucleus RadioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleus RadioPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleus RadioPharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nucleus RadioPharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.